WellCare Agrees To Pay $35.2M In Medicaid Fraud Investigation

div























Latest News For Medicare / Medicaid / SCHIP
Report Finds 60,000 KCHIP-Eligible Kentucky Children Lack Coverage, Urges Enrollment Boost
21 Aug 2008

Many Older Adults Cannot Find Most Beneficial Prescription Drug Plan On Medicare Web Site, Study Finds
21 Aug 2008

US Hospital Death Rates For Different Conditions Now Online
21 Aug 2008

View more news...

Today's Featured Health Videos









more videos ar available in our health videos discussion section.




Most Popular Categories

cancer �
cardiovascular �
dermatology �
hiv �
nutrition �

diabetes �
obesity �
pediatrics �
psychology �
neurology �
alcohol �

urology �
breast cancer �
women's health �
infectious diseases �
respiratory �
sexual health �

gastrointestinal �
pain �
pregnancy �
bones �
medical devices �
medicare �

depression �
prostate �
smoking �
alzheimer's �
allergy �
sleep �

biology �
genetics �
eye health �
sports medicine �
hypertension �
abortion �

health insurance �
autism �
stem cell research �
adhd �
liver disease �
multiple sclerosis �

arthritis �
pharma industry �
seniors �
dentistry �
it �
nursing �

blood �
fertility �

More info

• Most College Kids Have Thought of Suicide
• Online Autism Fund: Godsend or Money Pit?
• Clipboards face hacking threat
• Poor sleep equals high BP for teens
• ‘Video game players make few errors’

DOR BioPharma Announces Initiation Of Second Human Clinical Trial For RiVaxTM, Its Ricin Toxin Vaccine

� DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company"), a late-stage biopharmaceutical company, announced that one of its academic development partners has initiated a second human clinical trial of RiVax� in healthy volunteers. RiVax� is a recombinant subunit vaccinum designed to induce security against vulnerability to ricin toxin, a category B biothreat. This new trial is intended to judge the base hit and immunogenicity of an improved expression of the vaccine containing an ancillary that is expected to result in long durable and high levels of protective antibodies. The new trial is being conducted as erated and immunogenic in a Phase 1 clinical trial in normal volunteers.


For further information regarding DOR BioPharma, Inc., please visit the Company's internet site located at http://www.dorbiopharma.com.


This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, that reflect DOR BioPharma, Inc.'s current expectations about its future results, performance, prospects and opportunities, including statements regarding the potential use of orBec� for the treatment of gastrointestinal GVHD and the prospects for regulatory filings for orBec�. Where possible, DOR has tried to identify these forward-looking statements by victimisation words such as "anticipates," "believes," "intends," or standardised expressions. These statements ar subject to a

Amy Winehouse's mundane new album

Amy Winehouse sings around her pet foods on her newfangled album.

The Rehab singer�- wHO was recently hospitalised after she suffered convulsions at her London home�- is currently working on her third record album and has taken inspiration from her favourite meals while writing tracks.

A generator said: "When Amy�s working she gets loads of Caribbean solid food delivered to the studio. It can get a bit mussy sometimes. But that�s where Amy gets her psyche from - good old fashioned soul food."

The 24-year-old singer has previously revealed she often makes meatballs for her friends after nights out, and one of her new songs includes the line: "I